Plavix Hearing Scheduled For Aug. 18 After Sanofi/Bristol File Preliminary Injunction
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex launch of generic clopidogrel is the “largest ‘at-risk’ infringing launch of all time,” Sanofi/Bristol court filing claims.